Macular Edema News and Research

RSS
Quantel Medical wins FDA approval for innovative Easyret photocoagulator

Quantel Medical wins FDA approval for innovative Easyret photocoagulator

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda announces accelerated approval from FDA for new lung cancer treatment

Scientists discover novel therapeutic target for retinal neovascularization

Scientists discover novel therapeutic target for retinal neovascularization

New micro-pump technology may offer promising alternative to eye drops for glaucoma patients

New micro-pump technology may offer promising alternative to eye drops for glaucoma patients

Red color channel can help detect diabetic macular edema in racial/ethnic minority patients

Red color channel can help detect diabetic macular edema in racial/ethnic minority patients

Increased growth factor protects retinal blood vessels in animal models with diabetes

Increased growth factor protects retinal blood vessels in animal models with diabetes

Joslin scientists suggest new approach to improve stroke therapy

Joslin scientists suggest new approach to improve stroke therapy

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

New study reveals better treatment options for proliferative diabetic retinopathy

New study reveals better treatment options for proliferative diabetic retinopathy

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy

Ranibizumab may become reasonable treatment alternative for patients with proliferative diabetic retinopathy

Ranibizumab may become reasonable treatment alternative for patients with proliferative diabetic retinopathy

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

Allergan completes acquisition of AqueSys

Allergan completes acquisition of AqueSys

Envisia's ENV515 (travoprost XR) meets primary efficacy endpoint in phase 2a glaucoma trial

Envisia's ENV515 (travoprost XR) meets primary efficacy endpoint in phase 2a glaucoma trial

ILUVIEN continues to show positive results in Europe

ILUVIEN continues to show positive results in Europe

Alimera Sciences announces results from ongoing study on ILUVIEN

Alimera Sciences announces results from ongoing study on ILUVIEN

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

Bayer Yakuhin receives MHLW approval in Japan for EYLEA (aflibercept) Injection to treat RVO patients

Bayer Yakuhin receives MHLW approval in Japan for EYLEA (aflibercept) Injection to treat RVO patients

Bayer HealthCare, Johns Hopkins University to jointly develop new ophthalmic therapies targeting retinal diseases

Bayer HealthCare, Johns Hopkins University to jointly develop new ophthalmic therapies targeting retinal diseases